Editorial Comment to Impact of low-dose tadalafil on adverse events after low-dose-rate brachytherapy for prostate cancer: A bi-center randomized open-label trial

Int J Urol. 2021 Apr;28(4):438-439. doi: 10.1111/iju.14511. Epub 2021 Feb 7.

Authors

Nobuhiro Haga¹, Takeshi Miyazaki¹, Kazuna Tsubouchi¹, Yu Okabe¹

Affiliation

¹ Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.

PMID: 33550677
DOI: 10.1111/iju.14511

No abstract available

Publication types

Editorial
Comment

MeSH terms

Brachytherapy* / adverse effects
Erectile Dysfunction*
Humans
Male
Prostatic Neoplasms* / drug therapy
Prostatic Neoplasms* / radiotherapy
Tadalafil / adverse effects

Substances

Tadalafil